| Identification | Back Directory | [Name]
METHYL 4-AZA-5ALPHA-ANDROSTA-1-EN-3-ONE-17BETA-CARBOXYLATE | [CAS]
103335-41-7 | [Synonyms]
Finasteride EP Impurity B
Finasteride impurity B (EP)
(4aR,4bS,6aS,7S,9aS,9bS,11aR)
Finasteride Methyl Ester Analog
Dutasteride Methyl Ester Impurity
Methyl 3-Oxo-4-aza-5alpha-androst-1
Finasteride Impurity 2（Finasteride EP Impurity B）
methyl 3-oxo-4-aza-5α-androst-1-ene-17β-carboxylate
Finasteride Impurity B (Dutasteride Ester Impurity)
Dutasteride Ester Impurity (Finasteride EP Impurity B)
Finasteride EP Impurity B (Dutasteride Ester Impurity)
methyl-3- oxo-4-aza-5-alfa-androst-1ene-17-beta-carboxylate
METHYL 3-OXO-4-AZA-5-ALPHA-ANDROST-1-ENE-17-BETA-CARBOXYLATE
3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid Methyl Ester
METHYL 4-AZA-5ALPHA-ANDROSTA-1-EN-3-ONE-17BETA-CARBOXAMIDE(M4)
Dutasteride Methyl Ester Analog (Finasteride Methyl Ester Analog)
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-Methyl 4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-Methyl 4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7, 8,9,9a,9b,10,11,11a-t
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-Tetradecahydro-4a,6a-diMethyl-2-oxo-
-Methyl 4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate
Finasteride EP Impurity B/ Finasteride Related Compund D (Dutasteride Methyl Ester Analog/Finasteride Methyl Ester Analog)
methyl (1S,3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxylate
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-Methyl 4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate
1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, methyl ester, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- | [EINECS(EC#)]
600-422-0 | [Molecular Formula]
C20H29NO3 | [MDL Number]
MFCD00876749 | [MOL File]
103335-41-7.mol | [Molecular Weight]
331.45 |
| Chemical Properties | Back Directory | [Melting point ]
280-282°C (dec.) | [Boiling point ]
478.6±45.0 °C(Predicted) | [density ]
1.113±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
14.15±0.70(Predicted) | [color ]
White to Off-White | [InChI]
InChI=1S/C20H29NO3/c1-19-10-8-14-12(13(19)5-6-15(19)18(23)24-3)4-7-16-20(14,2)11-9-17(22)21-16/h9,11-16H,4-8,10H2,1-3H3,(H,21,22)/t12-,13-,14-,15+,16+,19-,20+/m0/s1 | [InChIKey]
WMSQGMYJYBSBKA-ALHYADCGSA-N | [SMILES]
N1[C@@]2([H])[C@@](C)([C@@]3([H])CC[C@@]4(C)[C@]([H])([C@]3([H])CC2)CC[C@@H]4C(OC)=O)C=CC1=O |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Uses]
Finasteride (F342000) and Dutasteride (D735000) impurity. An intermediate in the synthesis of Finasteride and Dutasteride, 5α-reductase inhibitors used for treatment of benign prostatic hyperplasia ac
ne, seborrhea, female hirsutism, prostatitis, and prostatic carcinoma and other hyperandrogenetic related disorders. | [Uses]
Finasteride (F342000) impurity. A novel intermediate in the synthesis of Finasteride, a 5α-reductase inhibitor used for treatment of benign prostatic hyperplasia acne, seborrhea, female hirsutism, prostatitis, and prostatic carcinoma and other hyperandrogenetic related disorders.
|
|
| Company Name: |
J & K SCIENTIFIC LTD.
|
| Telephone: |
18210857532 18210857532 |
| Website: |
https://www.jkchemical.com |
|